Donate

News

Latest news

Concern proposed bill may make cancer medication unaffordable for Kiwis

October 7, 2019

Wake-up call for cancer agency boss Diana Sarfati

October 4, 2019

Newsletter: October 2019

October 1, 2019,

Major biological processes involved in the development of myeloma uncovered

September 18, 2019

Real-World Insight on Patients With Multiple Myeloma: Results Drawn From a Large Health Plan

September 17, 2019

New Therapies for Blood Cancers Hold Promise

September 12, 2019

Reducing the Risk of Blood Clots in Patients With Multiple Myeloma

September 10, 2019

Myeloma Seminar for Patients, Families and Friends

September 9, 2019,

Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles

September 9, 2019

Government unveils national cancer agency and $60 million injection into Pharmac

September 2, 2019

Blood cancer more likely to affect relatives of people who have it, study shows

August 30, 2019

Multiple Myeloma Research Review

August 29, 2019

Suboptimal Implementation of Supportive Care in Older Patients With Multiple Myeloma

August 28, 2019

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

August 26, 2019

Dual CAR T-cell combination a ‘promising treatment option’ for multiple myeloma

August 21, 2019

Government urged to expand Pharmac’s drug budget after barrage of emotional pleas from sufferers

August 9, 2019

Health Select Committee hears pleas from survivors and sufferers

August 8, 2019

Blood cancer patient advocacy group presents to Health Select Committee to fund life-extending treatments

August 7, 2019

Dr. Nadeem on Individualizing Therapy in Multiple Myeloma

July 26, 2019

Improved Clinical Outcomes in Relapsed/Refractory Multiple Myeloma With Daratumumab Re-Treatment

July 11, 2019

New medicine for multiple myeloma shows promising results

July 9, 2019

Innovation Fuels Survival Gains in Multiple Myeloma

June 13, 2019

Daratumumab cuts risk for progression in multiple myeloma

May 31, 2019

Multiple Myeloma Research Review

May 28, 2019

Guyon Espiner investigates Pharmac: The NZ Buyer’s Club

May 23, 2019

Early Treatment for Smoldering Multiple Myeloma

May 22, 2019

Lenalidomide Offers Patients With Smoldering Myeloma Option to Prevent Progression

May 17, 2019

Living well with Myeloma

May 16, 2019,

More protests likely says cancer sufferer

May 14, 2019

Multiple Myeloma Imaging Strategies

May 9, 2019

Minimal residual disease status prognostic for PFS in myeloma

May 9, 2019

BCMA CAR-T bb2121 Appears to Be Safe and Effective in Multiple Myeloma

May 9, 2019

Blood cancer patients advocate pleads for funding for new treatments

May 7, 2019

Another march towards Pharmac funding

May 7, 2019

Petition calls on government to fund more lung cancer medications

May 7, 2019

Hundreds march on Parliament demanding government funding for cancer drugs

May 7, 2019

Hundreds demand Government funding for cancer drugs

May 7, 2019

Protestors petition government to fund life-extending cancer medication

May 7, 2019

Cancer sufferers and families deliver petitions to Parliament

May 7, 2019

Hundreds rally at Parliament to present petitions for better Pharmac funding

May 7, 2019

Pharmac chairman backs early access scheme for new drugs

May 7, 2019

Cancer sufferers deliver eight Pharmac funding petitions to Parliament

May 7, 2019

CAR T-Cell Therapy Emerges in Multiple Myeloma

May 6, 2019

Gene therapy may help fight tough-to-treat blood cancer

May 3, 2019

20k NZers sign petitions for better funding of medicines

May 3, 2019

Researchers discover how to prevent kidney damage in patients with multiple myeloma

May 2, 2019

JOIN THE MARCH

April 29, 2019

Newsletter: April 2019

April 16, 2019,

Patient Seminar with Prof. Nikhil C. Munshi: Minimal residual disease in Myeloma sessions

April 16, 2019

Imaging in multiple myeloma: How? When?

April 15, 2019,